Riley Antony A (CIK 1339375) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-27). Recent activity: Sell FBRX (42,600 shares), Buy FBRX (375 shares), Sell FBRX (134 shares), Buy FBRX (375 shares), Sell FBRX (134 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-27 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 42,600 | $0 |
| 2026-07-06 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 375 | $0 |
| 2026-07-06 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 134 | $2,857 |
| 2026-04-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 375 | $0 |
| 2026-04-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 134 | $3,331 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 9,680 | $254,874 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 375 | $0 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 154 | $4,200 |
| 2025-10-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 375 | $0 |
| 2025-10-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 134 | $1,946 |
| 2025-07-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Buy | 375 | $0 |
| 2025-07-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | Sell | 134 | $1,667 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27